PennyStocks101 Reports 3 TOP Stocks to Watch Closely: Uranium Resources, Map Pharmaceuticals, and Threshold Pharmaceuticals

Beverly Hills, CA -- (SBWIRE) -- 01/23/2013 -- http://www.PennyStocks101.com - The US leader in microcap breakouts, offers a high quality stocks alert newsletter to investors looking for the best breakout stocks around. PennyStocks101 reports 3 penny stocks to keep an eye on for a possible bounce or more gains: URRE, MAPP, and THLD

The market moved higher on Wednesday after strong earning reports from tech giants Google and IBM came in. The Dow Jones industrial average rose 57 points to 13,769 as of 10:10 a.m. EST. The Standard & Poor's 500 index was flat at 1,492. The NASDAQ composite rose 12 points to 3,155.

1. Uranium Resources (NASDAQ:URRE) - Uranium Resources declares reverse stock split of 1-for-10.

2. Map Pharmaceuticals (NASDAQ:MAPP) - Allergan, Inc. (NYSE:AGN) and MAP Pharmaceuticals, Inc. (NASDAQ:MAPP) today jointly announced that they have entered into a definitive merger agreement whereby Allergan will acquire 100% of the shares of MAP Pharmaceuticals for a price of $25.00 per share.

3. Threshold Pharmaceuticals (NASDAQ:THLD) - Threshold is focused on the discovery, development, and commercialization of small molecule therapeutics based on `Metabolic Targeting.`

Pennystocks101.com educates and shows investors the inner workings of the volatile world of penny stocks by scouring the markets for the hottest penny stocks that look poised to break out. Discover the next hidden company to profit. Sign up for the free newsletter to receive the next big report soon. Join at: http://www.PennyStocks101.com

Sign Up at - http://www.PennyStocks101.com for more ideas to put on your radar.

Disclosure
Pennystocks101.com and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. This press release may contain several forward looking statements. Please read our report and visit our website for complete risks and disclosures.